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The International Multi-Centre ADHD Gene sample consists of 674 families from eight countries (Belgium, England,
Germany, Holland, Ireland, Israel, Spain, and Switzerland) ascertained from clinics for combined-type attention definity
hyperactivity disorder in an offspring. 863 SNPs were successfully genotyped across 47 autosomal genes implicated in
psychiatric disorders yielding a single nucleotide polymorphism (SNP) density of approximately one SNP per 2.5 kb. A
global test of heterogeneity showed 269 SNPs nominally significant (expected 43). Inclusion of the Israeli population
accounted for approximately 70% of these nominally significant tests. Hardy-Weinberg equilibrium tests suggest that
combining all these populations would induce stratification, but that the Northern European populations (Belgium,
England, Germany, Holland, and Ireland) could be appropriate. Tag SNPs were generated using pair-wise and aggressive
tagging from Carlson et al. [2004] and de Bakker et al. [2005], respectively, in each population and applied to the other
populations. Cross-population performance across Northern Europe was consistent with within population comparisons.
Smaller sample size for each population tended to yield more problems for the generation of aggressive tags and the
application of pair-wise tags. Any case-control sample employing an Israeli sample with Northern Europeans must consider
stratification. A Northern European tag set, however, appears to be appropriate for capturing the variation across
populations. Genet. Epidemiol. 32:98–107, 2008. r 2007 Wiley-Liss, Inc.
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INTRODUCTION
Population differences have generated a great
deal of confusion in case-control association studies.
In particular, population stratification can yield both
positive and negative bias in association findings.
As a result, family-based designs such as the
Transmission Disequilibrium Test were developed
r 2007 Wiley-Liss, Inc.
[Spielman et al., 1993]. For case-control analyses,
geneticists have created methods based on back-
ground markers such as genomic control, structure,
and L-POP [Devlin and Roeder, 1999; Pritchard
et al., 2000; Devlin et al., 2001; Purcell and Sham,
2004]. At the same time, association analysis has
become more sophisticated with researchers now
routinely employing haplotype-based methods, tag-
ging single nucleotide polymorphisms (SNPs), and
general patterns of linkage disequilibrium (LD)
[Daly and Altshuler, 2005; Kruglyak, 1999; Palmer
and Cardon, 2005; Risch, 2000]. These methods aim
to improve efficiency by removing redundant
genotyping and gather additional association infor-
mation indirectly via LD, although the latter has also
raised questions about the nature of population
differences such as the consistency of LD structures
across populations and the similarity of observed
haplotypes [van den Oord and Neale, 2003; Evans
and Cardon, 2005; Gonzalez-Neira et al., 2006].
A number of studies have examined the consis-
tency of LD information in European samples. A key
component of such work is tag selection from the LD
information of the Centre d’Etude du Polymor-
phisme Humain (CEPH) sample. Mueller et al.
densely genotyped four gene regions (PLAU, SNCA,
LMNA, and FKBP5) at a frequency of one SNP per
2–4 kb in strictly European populations to gauge
populations differences [Mueller et al., 2005]. In
general, mild allele frequency differences were
detected. Aside from basic allele frequency differ-
ences, Mueller also looked at haplotype frequency
and block boundary position as outcome measures,
broadly noting that geographical distance correlated
quite strongly with observed differences between
the two populations. From a tagging perspective,
CEPH samples captured variation accurately in two
genes, and performed poorly in the other two,
indicating variability in the patterns of tagging.
de Bakker and colleagues recently examined the
extent to which population differences exist in
a comparison of various populations. For cross-
European tagging, the tags from the CEPH sample
were assessed in a Finish sample from the multi-
ethnic cohort study. Generally, the power to detect
association from tag SNPs is maintained in the
Finnish population [de Bakker et al., 2006]. Nejent-
sev et al. examined the vitamin D receptor gene in
four European populations and an African popula-
tion. All of the European populations showed
dramatically similar LD properties in the gene, and
that tags generated from the CEPH sample per-
formed reasonably well. The authors conclude that
the similarity of LD is consistent with the model
predicting no major founder effect for the Euro-
peans [Nejentsev et al., 2004]. Recently, Ribas et al.
published an examination of population differences
between a Spanish sample and the CEPH sample.
The correlations for allele frequency and LD were
0.91 and 0.95, respectively. Baucet and colleagues
explore the population structure of Europeans as
compared to the CEPH and Coriell samples. Broadly,
Europe splits into two main sets, a northern (Polish,
Irish, English, Germans, and some Italians) and a
southeastern (Greeks, Armenians, Jews, and some
Italians) [Bauchet et al., 2007]. Finally, Evans
and Cardon compared the recombination rates
across a region in chromosome 20 in the CEPH
and a UK sample. The results were quite similar for
the two populations, so the close ancestry appears to
predict similarity in LD structure [Evans and
Cardon, 2005].
In this paper, we present analysis of the simila-
rities and differences of populations across Europe
and Israel from the International Multi-Centre
ADHD Gene (IMAGE) sample, exploring 47 auto-
somal genes, many of which have been implicated in
psychiatric disorders.
METHODS
The IMAGE sample used in this study has been
detailed elsewhere [Brookes et al., 2006]. In brief, the
sample is composed of 674 families collected in eight
countries from 11 clinical centers: Belgium,
Germany, Holland, Ireland, Israel, Spain, Switzer-
land, and United Kingdom. We considered our
sample by looking at each ascertainment center
separately. As Germany, Holland, and Israel each
had two centers, for some analyses we combined
these sets of families, yielding eight sets of data
(with number of families in brackets): Swiss (24),
German (291805 109), Spanish (52), Israeli (261
975 123), Dutch (8411105 194), Belgian (22),
England (98), and Ireland (52).
Ethical approval for the study was obtained from
Ethical Review Boards within each country and
informed consent obtained for the use of the samples
for analyses relating to the genetic investigation of
attention definit hyperactivity disorder (ADHD). All
ADHD probands and their siblings were aged 5–17
years at the time of entry into the study and access
was required to one or both biological parents for
DNA collection. Diagnosis of ADHD was standar-
dized at the outset of the sample collection, so all
probands are based on the same phenotypic defini-
tion. Exclusion criteria applying to both probands
and siblings included autism, epilepsy, IQo70, brain
disorders, and any genetic or medical disorder
associated with externalizing behaviors that might
mimic ADHD. DNA was available for both parents
in 598 families (88.7%) and from one parent in 73
families (10.8%). 664 (85.6%) of the ADHD cases
were males. The age range for both probands and
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siblings was 5–17 years with a mean age of 11.2 years
(SD5 2.7) for probands and 11.2 years (SD5 3.1) for
siblings.
Gene selection focused on ‘‘biological systems’’ by
nominating 45 genes that were likely to exert an
effect through regulation of dopamine, serotonin,
and norepinephrine neurotransmission. Six addi-
tional genes were selected for their role in circadian
rhythm. Of these, four genes were sex-linked and
excluded from this analysis.
For SNP selection, we aimed at a comprehensive
analysis of each gene from two perspectives:
functionality and tagging. For the functional
markers, we targeted SNPs located within coding
regions (synonymous and non-synonymous), 50 and
30 untranslated regions, intron sequences within
300 bp from intron/exon boundaries, and one SNP
per kb covering 5 kb upstream from the start of
transcription or known 50 regulatory regions includ-
ing the promotor. For tagging we selected a non-
redundant set of tagging SNPs that showed r240.80
with SNPs with minor allele frequency (MAF) Z
0.05, using the CEPH panel from the HapMap [2003]
database. Tagging SNPs were selected using two
methods. We used the ‘‘CompleteLink routine’’
within CLUSTAG that implements a hierarchical
clustering algorithm (hkumath.hku.hk/web/link/
CLUSTAG/CLUSTAG.html) [Ao et al., 2005]. The
second method used the default algorithm in Haplo-
view (www.broad.mit.edu/mpg/haploview) from
Gabriel et al. [2002]. 39.6% (173 out of 437 tSNPs)
of the CLUSTAG SNPs and 71.8% (173 out of 241
tSNPs) of the Gabriel method SNPs were shared.
7.0% (77 out of 1,105, functional SNPs) were
included in the tag criteria. To avoid redundancy
of the marker information, where the two methods
recommended selection of two different SNPs that
fell within the same cluster defined by CLUSTAG,
we preferentially selected the tagging SNP recom-
mended by the CLUSTAG algorithm. If the con-
straints of the Illumina technology prevented the use
of an identified tagging SNPs nominated by CLUS-
TAG, then an alternative SNP located in the same
cluster was selected. At the time of SNP selection, it
was unclear what the most effective approach for
tagging a region is. As a result, we aimed to err on
the side of SNP inclusion to ensure that the variation
in each gene was well characterized.
Blood samples were sent to Rutgers University
Cell and DNA repository, New Jersey (RUCDR).
These were either used to generate lymphocyte cell
lines from which DNA was extracted, or DNA was
extracted directly from a portion of the blood sample
and lymphocytes cryopreserved for future recovery.
In a few cases where individuals were not able to
supply a blood sample, we used a mouth swab
sampling technique and extracted the DNA at the
SGDP laboratory in London [Freeman et al., 2003].
DNA stocks for the entire dataset were collated in
London where they were stored, organized and
plated out for further analysis. Geneservice Ltd
Cambridge (UK) performed whole-genome amplifi-
cation on all samples with o100 mg stock DNA,
using the REPLI-g kit (Qiagen Ltd, Crawley, Sussex).
DNA samples were arrayed into 96-well plates at a
concentration of 50 ng/mL and delivered to Illumina
Inc. (San Diego, CA).
SNP genotyping was completed using the
Illumina high-throughput BeadArrayTM technology
(http://www.illumina.com). We set a lower limit for
MAF of 0.05, but also included a high proportion of
non-validated SNPs and SNPs with unknown
heterozygosity from ‘‘functional’’ regions. Addition-
ally, we excluded variation on the sex chromosomes.
For this analysis we finished with a set of 863 SNPs
across 47 genes. The average SNP density was
approximately one SNP every 2.5 kb.
Ten samples of the total of 2,937 samples (o0.04%)
could not be genotyped even after multiple attempts
and were removed from the dataset. For the
remaining samples the average genotype drop out
rate was 0.02% (not including the 34 markers that
failed on the whole-genome amplification DNA).
The overall genotyping error was estimated to
be lower than 0.065% (0.06%10.005%). We identified
47 families with potential pedigree errors using
PEDCHECK [O’Connell and Weeks, 1998]. Within
these families the numbers of Mendelian errors
ranged from 16 to 312 and could not be explained by
genotyping errors. Forty errors could be corrected by
considering different familial relationships but
seven of these families exhibited unknown pedigree
errors and were removed from the analysis. The
final dataset for association analysis included 674
families that contained 156 sporadic Mendelian
errors from 987 autosomal markers. The overall
detection rate of Mendelian errors is therefore 0.02%,
which is consistent with the estimated efficiency of
SNP markers [13–75%; Douglas et al., 2002] to detect
such errors by identification of Mendelian errors and
an estimated overall genotype error rate o0.065%.
Pedigree errors may be explained by the compli-
cated procedures inherent within a large interna-
tional cooperative process. We also imposed a
threshold of the Illumina quality control score of
0.5 for all SNPs.
We employed three approaches to determine the
level of similarity across the subpopulations; hetero-
geneity tests, Hardy-Weinberg equilibrium (HWE)
tests, and tag SNPs comparisons (the number of tags
and the cross-population efficiency). Selecting only
markers that were polymorphic in all populations, a
w2 test was conducted on the allele counts by center
site and population group. The w2 was conducted
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using the program R 2.1.0, and the significance was
simulated using 2,000 replicates for each test. Each
center site or population group was subsequently
dropped from the heterogeneity analysis, to deter-
mine the effect on the distribution of results.
In addition to global heterogeneity analysis, pair-
wise analysis was conducted for every possible pair
of populations.
The goal of the heterogeneity analysis is to assess
allele frequency differences across the populations.
The global test of heterogeneity determines whether
the entire set of populations can be grouped together,
and by extension whether combined association
analysis is appropriate. The pair-wise tests aim to
illuminate the relative similarity between popula-
tions. In particular, the question of which populations
can be grouped together with little cost to association
analysis. These pair-wise tests are not attempting to
find significant differences, but rather explore how
similar these various populations are. Furthermore, r2
is affected by allele frequency, so allele frequency
differences are an important factor for consideration
in consistency of LD information. As a convenient
way to interpret the results broadly, we report the
number of SNPs with global heterogeneity test P-
value o0.05. The expectation for the number of tests
significant at this level is 5%, so for 863 SNPs, we
expect to observe approximately 43 differences
significant at the 0.05 level.
HWE tests were conducted in each subpopulation
and combined within countries. PLINK was used to
calculate the HWE test, using the w2 test [Purcell
et al., 2007]. Consistent deviations from Hardy-
Weinberg are a hallmark of population stratification.
Using the Tagger program implemented in Haplo-
view, we determined the number of tag SNPs to
capture all information across the region at an r2 of
0.8 or better [Carlson et al., 2004; Patil et al., 2001].
We employed both ‘‘pair-wise tagging’’ from
Carlson et al. and the ‘‘aggressive tagging’’ from
de Bakker et al. considering all variation [Carlson
et al., 2004; de Bakker et al., 2005]. We examined the
average number of tags necessary across all popula-
tions. We elected to use the number of tag SNPs
rather than specific tag SNPs as mild variation in the
observed r2 can cause different SNP selection.
Additionally, the number of SNPs rather than
specific SNPs ought to serve as an indication of the
amount of LD across each region. The efficacy of the
tags selected is measured by the cross-population
tagging performance. Each population was used as a
training set to generate tags and then those tags were
tested in every other population. Both tagging
approaches outlined above, pair-wise and aggres-
sive, were employed.
RESULTS
Comparing all population centers jointly yielded
269 out of 863 SNPs with a P-value o0.05. A kernel
density estimator plot of the distribution of P-values
can be found in Figure 1. Clearly, the overall
distribution of tests is biased heavily toward smaller
P-values. Such a result is an indication of major
population differences in allele frequencies. Allele
frequency differences are a major component of
population stratification, and important in the
consideration of association evidence.
Table I shows the number and percentage of tests
significant at a nominal 0.05 P-value level for all
pair-wise population comparisons and for the global
test conditional on dropping each center. In
Fig. 1. Distribution of P-values for 863 markers in population heterogeneity analysis. The solid line represents the distribution of
P-values from the full heterogeneity analysis. The dotted line represents the expected uniform distribution of P-values under the null
model of no allele frequency differences.
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instances of multiple centers in a country, these
centers were combined and dropped.
Figure 2 shows the distribution of HWE tests for
each population, and country. Additionally, global
and Northern European (Belgium, England,
Holland, Germany, Ireland) sets were tested. Ex-
tensive data cleaning has already taken place (see
above), so some evidence for differences may have
already been removed.
Figure 3 shows the HWE tests for the Nor-
thern European set. These two figures show the
radically different amount of deviation from HWE
observed in the combined sample, versus the
Northern European sample. Deviation from HWE
is a hallmark of population stratification, and so
these results further confirm the relative difference
of the Israeli populations from the Northern Eur-
opeans.
Table II shows the number of SNPs necessary to
characterize the entire set of markers using both the
pair-wise and aggressive tagging approaches. For
both of these approaches, a minimum R2 threshold
of 0.8 for all markers in the region was set. The
correlations between the number of tag SNPs and
sample size are 0.28 and 0.81 for pair-wise and
aggressive tagging, respectively.
Tables III contains the cross-tagging performance
in terms of percentage of SNPs captured by the
pre-defined tagging set. Across the datasets, we
have a range of sample sizes. In general, larger
populations show more pair-wise tags and fewer
aggressive tags. The correlation between tag number
and sample size is considerably stronger in the
aggressive tagging approach.
DISCUSSION AND CONCLUSION
As shown in Table I, the allelic heterogeneity
analysis shows clear allele frequency differences
between the Israeli populations and the rest of the
European populations. Furthermore, allele fre-
quency comparisons between Northern European
populations show considerably less heterogeneity.
The Northern European populations may still hold
population differences at a finer level which are not
picked up, given the sample size and subset of all
genome variation genotyped in our analysis. As
indicated by Bauchet et al. Southeastern and
Jewish populations ought not be grouped together
with Northern European populations as there are
significant differences [Bauchet et al., 2007].
TABLE I. The number and percentage of markers nominally significant for a simple v2 heterogeneity test
BE CH DE1 DE2 EN ES IL1 IL2 IR NL1 NL2
BE 290
(0.336)
CH 39
(0.045)
288
(0.334)
DE1 21
(0.024)
28
(0.032)
285
(0.33)
295
(0.342)
DE2 23
(0.027)
51
(0.059)
37
(0.043)
283
(0.328)
EN 30
(0.035)
69
(0.08)
30
(0.035)
31
(0.036)
273
(0.316)
ES 37
(0.043)
42
(0.049)
56
(0.065)
69
(0.08)
63
(0.073)
278
(0.322)
IL1 99
(0.115)
89
(0.103)
91
(0.105)
119
(0.138)
137
(0.159)
106
(0.123)
253
(0.293)
81
(0.094)
IL2 138
(0.16)
114
(0.132)
119
(0.138)
253
(0.293)
257
(0.298)
166
(0.192)
26
(0.03)
142
(0.165)
IR 47
(0.054)
57
(0.066)
47
(0.054)
78
(0.09)
67
(0.078)
71
(0.082)
155
(0.18)
266
(0.308)
259
(0.3)
NL1 61
(0.071)
54
(0.063)
61
(0.071)
46
(0.053)
66
(0.076)
96
(0.111)
150
(0.174)
279
(0.323)
87
(0.101)
269
(0.312)
243
(0.282)
NL2 46
(0.053)
59
(0.068)
43
(0.050)
51
(0.059)
53
(0.061)
105
(0.122)
169
(0.196)
309
(0.358)
88
(0.102)
35
(0.041)
256
(0.297)
BE: Ghent, Belgium; CH: Zurich, Switzerland; DE1: Essen, Germany; DE2: Goettingen, Germany; EN: London, England; ES: Valencia, Spain;
IL1: Jerusalem, Israel; IL2: Tel Aviv, Israel; IR: Dublin, Ireland; NL1: Amsterdam, the Netherlands; NL2: Nijmegen, the Netherlands.The cells
at the cross of the same population, refer to the number of tests that are nominally significant when excluding that population from the
analysis (e.g. the 1st cell shows the exclusion the BE population from the heterogeneity analysis, with 290 tests nominally significant). The
numbers in bold refer to dropping both population centers (DE, IL, and NL) from a country (e.g. removing both DE populations leaves 295
nominally significant tests). The rest of the table contains the number of nominally significant tests from pair-wise population
comparisons.The number of tests nominally significant considering all populations is 269.
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The HWE tests presented in Figure 2 show that
each country is largely behaving in an appropriate
fashion from a genotype distribution perspective.
Additionally, the HWE tests suggest that the North-
ern Europeans are largely similar given the relative
uniform nature of the P-value distribution.
For the cross-tagging performance, the three
countries with two centers each can be considered
a convenient benchmark for comparison. Accord-
ingly, the Belgian, English, German, Dutch, Irish,
and to a lesser extent Swiss appear similar for pair-
wise tagging, with the Spanish, and Israelis more
distinct. Other work in this vein indicates that the
CEPH sample, which is of Northern European
ancestry, provides a good tagging set [de Bakker
et al., 2006; Gonzalez-Neira et al., 2006; Nejentsev
et al., 2004]. However, the sample size appears to be
the distinguishing factor in terms of performance
when using aggressive tagging. Considering the two
centers in each population, the smaller populations
perform as better training sets for the larger
populations for pair-wise tagging, than vice versa.
One possible reason is that the error for the estimate
of the allele frequency is greater in smaller popula-
tions. As a result, rare SNPs are more likely to be
included and more common SNPs are more likely to
be excluded from the smaller populations. Aggres-
sive tagging suffers more in cross-population
comparisons because of the increased importance
of LD information.
Work on population differences using measures of
similarity such as heterogeneity tests and the
number of tagging SNPs may be colored by
phenotypic considerations. Such measures could
potentially differ because of ascertainment biases,
allelic or locus heterogeneity. Even with that quali-
fication, results in this paper may be confounded
with association signals or imposed selection.
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Fig. 3. Distribution of Hardy-Weinberg tests in the Northern European and all populations. The distribution of Hardy-Weinberg tests
across the 863 markers for Northern Europe and all populations combined. Northern Europe is composed of Belgium, Germany 1 and 2,
Holland 1 and 2, England, and Ireland.
TABLE II. Number of tag SNPs necessary to characterize
each population
Population
No. of
families
No. of pair-wise
tags
No. of aggressive
tags
BE 22 534 485
CH 24 530 488
DE1 29 534 483
DE2 80 540 461
EN 98 537 439
ES 52 544 469
IL1 26 543 494
IL2 97 555 467
IR 52 527 441
NL1 84 526 449
NL2 110 538 435
Total 674 542 
BE: Ghent, Belgium; CH: Zurich, Switzerland; DE1: Essen,
Germany; DE2: Goettingen, Germany; EN: London, England; ES:
Valencia, Spain; IL1: Jerusalem, Israel; IL2: Tel Aviv, Israel; IR:
Dublin, Ireland; NL1: Amsterdam, the Netherlands; NL2: Nijme-
gen, the Netherlands.
Pair-wise tagging refers to the Carlson et al., 2004 method.
Aggressive tagging refers to the de Bakker et al., 2005 method.
Both of these tags algorithms were implemented using Haploview
and Tagger.
Mean number of tags across the centres is 537.0 for pair-wise
tagging and 464.6 for aggressive tagging.
The correlation between the number of families and number of
tags across centres is 0.28 for pair-wise tagging and 0.82 for
aggressive tagging.
Computer memory restrictions prevented a global analysis of
aggressive tagging.
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For example, Zaykin et al. [2006] have recently
published a method to examine differences in LD
structure as evidence for association.
The marker selection approach utilized for tag
selection creates an obvious bias toward markers
with a more common than average MAF. First,
current SNP databases are enriched for more
common markers, as they are easier to detect.
Additionally, we used a tagging approach with a
condition on the MAF of the SNPs necessary to be
tagged. More common markers might show a
different pattern of variation between populations
than rare alleles. Also, private alleles for some
subpopulations, such as the Spanish and the Israeli,
might be underrepresented in HapMap samples,
yielding to a bias away from observable population
differences. Finally, the marker selection protocol for
the tags at the outset of the project causes bias in the
relative tagging efficiency in these regions.
We selected our families based on the presence of a
clinical phenotype and looked at genes with a strong
functional hypothesis in relation to the selected
phenotype. While this may limit the generalizability
of some of the conclusions to the general population,
most of the samples in genetics are of clinical
populations. So, while this is a limitation from a
general population perspective, it also is advanta-
geous from the perspective of seeing how much
clinical populations vary on heterozygosity and
tagging. The pooling of samples from different sites
within the same country could potentially deflate the
differences that we could observe.
In general, variation between populations tends to
diminish as the populations become more homo-
genous. The German, Dutch, Belgian, Irish, and
English cohorts show relatively little difference
between each other, while the Spanish, Swiss, and
Israeli samples tend to differ more greatly from the
Northern Europeans. However, this difference is far
smaller than that observed in surveys of more
diverse populations (e.g. Africans vs. Caucasian
Europeans) [Crawford et al., 2004]. Finally, while
TABLE III. Cross-population tagging performance for pair-wise tagging
Pair-wise tag generation
BE DE1 DE2 NL1 NL2 IL1 IL2 ES CH IR EN
Tag Application
BE 1.00 0.91 0.90 0.93 0.92 0.88 0.87 0.89 0.92 0.93 0.91
DE1 0.94 1.00 0.93 0.94 0.93 0.92 0.91 0.92 0.95 0.95 0.93
DE2 0.97 0.96 1.00 0.96 0.97 0.93 0.92 0.95 0.96 0.97 0.96
NL1 0.96 0.94 0.93 1.00 0.94 0.93 0.91 0.93 0.95 0.96 0.94
NL2 0.96 0.94 0.94 0.96 1.00 0.91 0.91 0.93 0.94 0.97 0.94
IL1 0.93 0.93 0.91 0.93 0.92 1.00 0.92 0.91 0.94 0.93 0.93
IL2 0.96 0.96 0.95 0.96 0.95 0.96 1.00 0.95 0.96 0.97 0.95
ES 0.96 0.94 0.95 0.96 0.96 0.94 0.93 1.00 0.95 0.97 0.95
CH 0.92 0.92 0.90 0.92 0.91 0.90 0.87 0.89 1.00 0.93 0.91
IR 0.95 0.94 0.92 0.95 0.94 0.91 0.90 0.92 0.94 1.00 0.93
EN 0.96 0.95 0.95 0.96 0.96 0.94 0.93 0.95 0.96 0.97 1.00
Agressive tag generation
BE 1.00 0.93 0.93 0.94 0.94 0.90 0.91 0.92 0.94 0.94 0.93
DE1 0.93 1.00 0.93 0.94 0.94 0.90 0.91 0.92 0.94 0.95 0.94
DE2 0.88 0.87 1.00 0.94 0.96 0.85 0.90 0.91 0.88 0.92 0.94
NL1 0.89 0.88 0.92 1.00 0.94 0.85 0.90 0.90 0.89 0.93 0.92
NL2 0.86 0.86 0.93 0.93 1.00 0.84 0.87 0.87 0.88 0.92 0.91
Tag Application IL1 0.91 0.92 0.91 0.93 0.93 1.00 0.92 0.92 0.94 0.93 0.93
IL2 0.88 0.90 0.91 0.93 0.93 0.87 1.00 0.90 0.90 0.93 0.92
ES 0.91 0.91 0.95 0.96 0.95 0.89 0.94 1.00 0.93 0.95 0.95
CH 0.91 0.92 0.92 0.94 0.94 0.87 0.88 0.91 1.00 0.94 0.92
IR 0.89 0.90 0.93 0.93 0.94 0.86 0.89 0.90 0.90 1.00 0.93
EN 0.89 0.88 0.94 0.94 0.96 0.86 0.91 0.92 0.90 0.94 1.00
BE: Ghent, Belgium; CH: Zurich, Switzerland; DE1: Essen, Germany; DE2: Goettingen, Germany; EN: London, England; ES: Valencia, Spain;
IL1: Jerusalem, Israel; IL2: Tel Aviv, Israel; IR: Dublin, Ireland; NL1: Amsterdam, the Netherlands; NL2: Nijmegen, the Netherlands.
Tag generation refers to the training set for the tags. Thus, each column refers to the same tag set generated by each centre. Each row refers
to the efficacy of tagging in each population in terms of percentage of SNPs that are captured at or above an r2 of 0.8 or better. For example,
the performance of the two German populations (DE1 and DE2) in each other for pair-wise tagging is as follows: For the tag set defined in
DE1 and applied in DE2 the percentage of SNPs captured at or above 0.8 is 96%, while the tag set defined in DE2 and applied in DE, the
percentage of SNPs captured at or above 0.8 is 93%.
105IMAGE Project
Genet. Epidemiol. DOI 10.1002/gepi
variation changes between populations it appears
that the amount of LD structure in each region is
relatively similar.
Any case-control association study using these
populations together ought to consider using geno-
mic control or a population classification system in
conjunction with a statistical technique for combin-
ing evidence across groups, such as the Mantel-
Haenszel technique. Additionally, the Israeli sample
requires more tags than the other populations, after
correcting for sample size, indicating that the CEPH
sample defined tag set used to define the marker
selection did not capture all the variation in the
Israeli population. In general, most investigations
into LD differences find that Northern Europeans
can be grouped together for the purposes of
generating and applying tag SNPs [Mueller et al.,
2005; Gonzalez-Neira et al., 2006; de Bakker et al.,
2006]. Southern Europeans and Israelis tend to form
a different population cluster [Bauchet et al., 2007].
Our results are largely consistent with these ob-
servations in the context of genes implicated is
psychiatric disorders.
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